A Randomized, Parallel, Double-dummy, Multi-center Phase III Study for Evaluation of Efficacy and Safety of Nasotestt Compared to Androgel Treating Hypogonadism in Male Research Participants.
This is a phase III study for evaluation of Nasotestt efficacy compared to Androgel in the treatment of male participants with hypogonadism condition (reduced levels of testosterone) that have clinical indication of hormonal replacement with testosterone.
100 Clinical Results associated with FBM Industria Brasileira Ltda
0 Patents (Medical) associated with FBM Industria Brasileira Ltda
100 Deals associated with FBM Industria Brasileira Ltda
100 Translational Medicine associated with FBM Industria Brasileira Ltda